GENERAL SUBMISSION INFORMATION AND DEADLINES

Don’t miss out on a great opportunity to submit an abstract for the 46th Annual ONS Congress.

ONS is accepting abstracts in the following categories:

• Clinical Practice
• Advanced Practice
• Leadership/Management/Education
• Research
• Quality Improvement
• International
• Non-NCPD Industry Supported

During the submission process, you will also select the subcategory that best describes your abstract. If your abstract is accepted for poster presentation, it will be grouped with other posters in the same subcategory. Please note: Research abstracts have unique subcategories, listed in the research section below.

• Coordination of Care
• End of Life
• Oncology Nursing Practice
• Patient Education and Safety
• Professional Development
• Psychosocial Dimensions of Care
• Screening, Early Detection, and Genetic Risk
• Survivorship
• Symptom Management and Palliative Care
• Treatment Modalities

Selection of abstracts will be based solely on a blind peer review. Abstracts may be selected for oral presentation sessions or e-Poster presentations and published in the online Oncology Nursing Forum .

Please note: accepted abstracts cannot be edited after acceptance and will be published as received. Pay close attention to spelling, grammar, names, and credentials.

IMPORTANT DEADLINES

1. GUIDELINES

   1. All abstracts must be submitted by the primary author electronically.
      
   2. For abstracts with more than one author, the primary author will be the contact person and presenter. All communication will be sent to the primary author only.
   3. All references that could identify the author/investigators by name or organization within the body of the text should be removed.
   4. The components of the abstract are divided into sections to help authors assure that they have included all the required information based upon the scoring criteria. Authors are encouraged to write the abstract in a word processing file (e.g. MS Word) and then cut and paste the appropriate sections into the abstract system.  Please double check to ensure special characters copied correctly. No edits can be made prior to publishing.
   5. The final abstract (body of abstract) must be no more than 375 words (excluding the title and authors’ names/institutions). Abstracts that contain more than the specified number of words will not be reviewed. Check the word count of your abstract in a word processing program prior to cutting and pasting the sentences into the online submission form.
   6. Attached Figure: You may include one image file with your abstract. You may include more than one figure or image in the single file. All figures or images on file must have titles. Words in the image file are not deducted from the total character count. Image files will not be included in publication.
      
   7. The abstract cannot be submitted unless all required fields are completed.
   8. The abstract title should clearly indicate the nature of the subject. Acronyms should not be used in the title and should be written out on first mention.  A quantifiable objective must be submitted and the body of the abstract should be in paragraph form, using complete sentences, and avoiding special characters. Abstracts should include, no more than six authors' names (first and last names), credentials, and institution or place of employment’s name, city and state. Abstracts should have all funding sources written out completely if applicable.
      
   9. The abstract must be approved by the authors’ employing institution(s).
   10. No previously published or presented (aka encore) abstracts will be accepted. Secondary analyses are acceptable. 2020 ONS Congress abstracts are ineligible for resubmission as they have been published. All submissions will be reviewed for originality via iThenticate. Abstracts identified as previously published will be removed from consideration for the 2021 ONS Congress.
   11. Research in progress will be considered for e-Poster presentation only. Consider submitting abstract in late breaking call for abstracts (December 7, 2020 - January 7, 2021) if data isn't available for first abstract call. Please note, only research and industry-supported abstracts will be considered in the late breaking submission period.
   12. Data published in abstracts accepted are embargoed until the conclusion of the presentation. Coverage and/or distribution of an abstract, poster, or any of its supplemental material to or by the news media, any commercial entity, or individuals, including the authors of said abstract, is strictly prohibited until the embargo is lifted.
   13. Authors retain copyright ownership of all original material submitted.
   14. Abstracts MUST be submitted by 5 pm EST, on Thursday, January 7, 2021.

2. AUTHORSHIP

   Primary authors must be either a registered nurse, a licensed healthcare professional from another discipline (physician, pharmacist, physical therapist, etc.), or a doctorally-prepared individual.

   For abstracts with more than one author, the primary author is the sole contact person and presenter.

   Abstracts submitted must be of the author’s own completed work, work in progress, or work previously presented at the local or regional level. However, abstracts may not be submitted that contain information that has been previously published or presented to national or international oncology nursing audiences.

   All primary abstract authors must complete the Presenter Agreement to meet the ONS NCPD Provider Unit requirements. This form is available in the submission system and includes the following.

   • Full Disclosure/Conflict of Interest

   Financial relationships are relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options, or other ownership interest, excluding diversified mutual fund(s), or other financial benefit. Financial relationships can also include “contracted research” where the institution gets the grant and manages the funds and the individual is the principal or named investigator on the grant. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ANCC considers relationships of the person involved in the NCPD activity to include financial relationships of a spouse or significant other. A relevant financial relationship is any relationship in any amount occurring in the past 12 months (as of the date that the form is completed) that creates a conflict of interest.  There is a lot of press recently on commercial influence over continuing education in medicine and nursing.  It’s important to identify potential conflicts to the planning team as well as to the audience. Without this information, there is not full disclosure. Without full disclosure there is the implication there is information to hide and bias is inherent in hiding information.

   • Warranty & Indemnity

   Warrant that you are the author of your presentation, that the presentation is original, except for such excerpts from copyrighted material included with the permission of the copyright owner and that you indemnify or release ONS against any and all liabilities, claims, or damages that would arise. You agree that the presentation is your own work, excerpts of copyright of materials are used with the expressed permission of the owner, presentation has not been developed as part of another presentation, and that it may be included within the ONS marketing materials.

3. THE REVIEW PROCESS

   1. Upon receipt, the abstract will be reviewed for compliance with the abstract instructions and assigned a number to ensure anonymity.
   2. Three ONS member volunteers with the appropriate experience in in leadership, management, education, clinical/evidence-based practice or research will blind review all abstracts.
   3. Reviewers will use one of the following sets of scoring criteria, depending on the abstract’s content area. Each item is scored on a scale of 1-5 grading scale (1=not at all; 5=high).
   4. The conference planning team will rank order abstracts for presentation at the conference.

CLINICAL PRACTICE, ADVANCED PRACTICE, LEADERSHIP/MANAGEMENT/EDUCATION, QUALITY IMPROVEMENT, AND INTERNATIONAL ABSTRACTS

1. ABSTRACT PRESENTATION FORMATS

   Oral Abstracts

   Abstracts accepted for oral presentations are offered in a session with four to six other abstracts and grouped by related category to be delivered for presentation. Speakers generally have 10-15 minutes to present their abstract and should include time for questions and answers. Only the PRIMARY AUTHOR may present the oral presentation session. Additional or substitute presenters are not permitted. Primary authors of abstracts selected for a podium presentation will be asked to submit a PowerPoint presentation.

   e-Poster Abstracts

   The submitter's prepared poster will display the process and outcome of a scientific or professional project. All presenters will submit their electronic poster directly to the e-Poster vendor. Further directions and e-Poster specifications will be provided after acceptance. e-Posters are available for viewing before, during, and after ONS Congress. Authors of accepted e-Poster abstracts MUST be present at the assigned presentation monitor during their assigned session at the conference to allow for dialog with participants.

2. ABSTRACT SCORING

   Abstracts will be scored using a 1-5 ranking on the following seven criteria.

   1. Significance and Background

      1. Is the topic significant, important, or relevant to oncology nursing practice?
      2. Is unique role or contribution of nursing described?
      3. Is the background of the problem summarized?

   2. Purpose

      1. Does the purpose clearly describe the project or activity?
      2. Is the rationale for the topic logical and supported by the information presented?

   3.  Interventions

      1. Does the intervention or practice describe how the purpose was accomplished?
      2. Are the interventions or practices described appropriately for the topic?
      3. Are nursing-sensitive patient outcome interventions described if appropriate?

   4. Evaluation

      1. Are the project goals evaluated according to specific measures?
      2. Are the outcomes applicable to oncology nursing?

   5. Discussion

      1. Are the implications for oncology nursing practice identified?
      2. Are the suggestions for using the information included?

   6. Presentation

      1. Is the abstract well written?
      2. Are the ideas clearly communicated?

   7.   Innovative

      1. Is this an innovative/cutting edge topic?

RESEARCH ABSTRACTS

1. ABSTRACT PRESENTATION FORMATS

   Oral Abstracts

   Abstracts accepted for oral presentations are offered in a session with four to five other abstracts and grouped by related category to be delivered for presentation. Speakers generally have 10-15 minutes to present their abstract and should include time for questions and answers. Only the PRIMARY AUTHOR may present the oral presentation session. Additional or substitute presenters are not permitted. Primary authors of abstracts selected for a podium presentation will be asked to submit a PowerPoint presentation.

   e-Poster Abstracts

   The submitter’s prepared poster will display the process and outcome of a scientific or professional project. All presenters will submit their electronic poster directly to the e-Poster vendor. Further directions and e-Poster specifications will be provided after acceptance. e-Posters are available for viewing before, during, and after ONS Congress. Authors of accepted e-Poster abstracts MUST be present at the assigned presentation monitor during their assigned session at the conference to allow for dialog with participants.

   Moderated e-Posters

   A select number of e-Posters will be included in moderated poster sessions and poster walks. e-Poster authors will be notified of selection and e-Poster presentation specifics if selected. Abstracts will be presented with a moderator asking clarification questions to the authors and moderating questions from the audience.

2. RESEARCH ABSTRACT SUBCATEGORIES

   • Symptom Science
   • Health Disparities
   • Palliative and Psychosocial Oncology Care
   • Complex Research Designs and Advanced Methods
   • Aging
   • Survivorship
   • Healthcare Delivery
   • Genetics/genomics/biosignatures
   • Data Science
   • Implementation/Improvement/Team Science

3. ABSTRACT SCORING

   Abstract scoring adapted (with permission) from the 2019 International Nursing Association for Clinical Simulation and Learning (INACSL) Research Rubric.

   Abstracts will be scored using a 1-5 ranking on the following six criteria. View the complete research scoring rubric here.

   1 = Emerging; 2 = Developing; 3 = Good; 4 = Very Good; 5 = Excellent

   1. Title

      1. Does the title clearly convey the study design, variables and study population?
      2. Is the title fully relevant to oncology nursing science?

   2. Purpose and Problem Statement

      1. Is the purpose/problem statement fully clear?

   3. Significance

      1. Does the content fully address gaps and current literature to further oncology nursing science?

   4. Methods

      1. Is the study design, sampling methods, sample size, procedures, instruments, and data analysis fully appropriate and consistent with the purpose of the study?

   5. Findings and Interpretation

      1. The results or the salient findings are fully summarized, and the author(s) interpretation of the data is fully presented.

   6. Discussion and Implications

      1. Is discussion fully clear, logical and congruent with the study's purpose, methods, or findings?
      2. Do findings fully define implications for nursing science, patient outcomes, nursing practice, education, administration, leadership and/or policy making?

   7. Presentation

      1. Is the writing style fully scholarly and fully clear to the reader?
      2. Is the abstract free of spelling or grammatical errors, and does the author use appropriate wording?

   8. Innovative

      1. Is this a fully innovative approach (e.g., topic and/or methods)?

INDUSTRY-SUPPORTED ABSTRACTS

1. INFORMATION

   Industry-supported abstracts are identified as projects that the researcher or presenter are employees of a pharmaceutical or related company. Also, any project that has been solely funded or directed by a company would be considered industry supported. Projects that have received unrestricted grant funding in which the researcher or principal investigator maintained full control over the project would not be considered industry supported.

   Pharmaceutical company or industry employees may submit an abstract featuring their employer’s products or services if they fully disclose their employment and/or financial involvement. Abstract presentations may not be sales presentations and must not imply the Society’s endorsement of said products or services. The individual making the presentation must clarify this point during the presentation. All pharmaceutical or industry sponsored abstracts are strongly encouraged to address nursing role, implications for nursing research, or clinical practice.

   Researchers wishing to submit an abstract containing data related to a clinical pharmaceutical or industry trial conducted at their institution, must provide full disclosure of the presenter’s affiliation with the company, any financial gains (honoraria, travel reimbursement etc.) received, research support obtained, or involvement of the company in the research, as well as a complete list of all contributors (physicians, statisticians etc.) on the abstract submission. Failure to provide such disclosure will result in the automatic rejection of the abstract. The member is expected to add a nursing dimension to the existing clinical trial data to make such data interesting and applicable to the conference attendees.

   Primary authors may decline acceptance or withdraw presentation of an abstract selection by emailing conferences@ons.org . No NCPD will be awarded for these abstracts due to ANCC guidelines stating that content must be free of commercial influence.

2. ABSTRACT PRESENTATION FORMATS

   e-Poster Abstracts

   The submitter’s prepared poster will display the process and outcome of a scientific or professional project. All presenters will submit their electronic poster directly to the e-Poster vendor. Further directions and e-Poster specifications will be provided after acceptance. e-Posters are available for viewing before, during, and after ONS Congress. Authors of accepted e-Poster abstracts MUST be present at the assigned presentation monitor during their assigned session at the conference to allow for dialog with participants.

3. ABSTRACT SCORING

   Abstracts will be scored using a 1-5 ranking on the following seven criteria.

   1. Significance and Background

      1. Is the topic significant, important, or relevant to oncology nursing practice?
      2. Is unique role or contribution of nursing described?
      3. Is the background of the problem summarized?

   2. Purpose

      1. Does the purpose clearly describe the project or activity?
      2. Is the rationale for the topic logical and supported by the information presented?

   3. Interventions

      1. Does the intervention or practice describe how the purpose was accomplished?
      2. Are the interventions or practices described appropriately for the clinical topic?
      3. Are nursing-sensitive patient outcome interventions described if appropriate?

   4. Evaluation

      1. Are the project goals evaluated according to specific measures?
      2. Are the outcomes applicable to oncology nursing?

   5. Discussion

      1. Are the implications for oncology nursing practice identified?
      2. Are the suggestions for using the information included?

   6. Presentation

      1. Is the abstract well written?
      2. Are the ideas clearly communicated?

   7. Innovative

      1. Is this an innovative/cutting edge topic?